The white paper contains the highest priorities and a research framework for the systemic amyloidosis diseases. This consensus document was developed through a rigorous process with the participation of 71 international experts from academic, clinical, regulatory, patient advocacy, health policy, industry, and other key areas. This publication is intended to identify, improve and accelerate a drug development pathway for the systemic amyloidosis diseases.
Patient Resources
Advancing Amyloidosis: A Research Roadmap
Related Content
-
Current ATTR landscape: Treatments and TrialsWebinars, ARC Talks
-
Amyloidosis and Nutrition: Eating for Your HealthWebinars, ARC Talks
-
Gastrointestinal Involvement in AmyloidosisLibrary, Patients
Get the latest Amyloidosis news and research from ARC.
Join our newsletter